Outcomes of partially covered self-expandable metal stents with different uncovered lengths in endoscopic ultrasound-guided hepaticogastrostomy: a Japanese retrospective study
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: The optimal length of the uncovered portion of partially covered self-expandable metal stents (PCSEMSs) used in endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) remains unclear. This study investigated the safety and efficacy of PCSEMSs with different uncovered lengths, with a focus on stent migration and time to recurrent biliary obstruction (RBO). Methods: Outcomes of patients undergoing EUS-HGS using PCSEMSs with 5-mm and 20-mm uncovered portions at our institution from January 2016 to December 2021 were compared. Results: Sixty-two patients underwent EUS-HGS using PCSEMS (5/20-mm uncovered portions: 32/30). Stent migration occurred only in the 5-mm group. There were no differences in RBO rates (28.1% vs. 40.0%) or median time to RBO (6.8 vs. 7.1 months) between the two groups. Median overall survival (OS) was longer in the 20-mm group (3.1 vs. 4.9 months, p=0.037) due to the higher number of patients that resumed chemotherapy after EUS-HGS (56.7% vs. 28.1%, p=0.029). Good performance status, absence of hepatic metastases, and chemotherapy after EUS-HGS were independent predictors of longer OS. Conclusions: No migration was observed in patients treated with PCSEMS with 20-mm uncovered portions. Patients treated with PCSEMS with 20-mm uncovered portions performed at least as well as those treated with 5-mm uncovered portions in all material respects.
Abstract
Background/Aims: The optimal length of the uncovered portion of partially covered self-expandable metal stents (PCSEMSs) used in endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) remains unclear. This study investigated the safety and efficacy of PCSEMSs with different uncovered lengths, with a focus on stent migration and time to recurrent biliary obstruction (RBO). Methods: Outcomes of patients undergoing EUS-HGS using PCSEMSs with 5-mm and 20-mm uncovered portions at our institution from January 2016 to December 2021 were compared. Results: Sixty-two patients underwent EUS-HGS using PCSEMS (5/20-mm uncovered portions: 32/30). Stent migration occurred only in the 5-mm group. There were no differences in RBO rates (28.1% vs. 40.0%) or median time to RBO (6.8 vs. 7.1 months) between the two groups. Median overall survival (OS) was longer in the 20-mm group (3.1 vs. 4.9 months, p=0.037) due to the higher number of patients that resumed chemotherapy after EUS-HGS (56.7% vs. 28.1%, p=0.029). Good performance status, absence of hepatic metastases, and chemotherapy after EUS-HGS were independent predictors of longer OS. Conclusions: No migration was observed in patients treated with PCSEMS with 20-mm uncovered portions. Patients treated with PCSEMS with 20-mm uncovered portions performed at least as well as those treated with 5-mm uncovered portions in all material respects.
참고문헌 (29)
- Isayama H, "Clinical practice guidelines for safe performance of endoscopic ultrasound", ultrasonography-guided biliary drainage : 2018, 2019, pp.26, 249~269
- van der Merwe SW, "Therapeutic endoscopic ultrasound : European Society of Gastrointestinal Endoscopy(ESGE)Guideline", Endoscopy, 54, pp.185~205 (2022)
- Khashab MA, "International multicenter comparative trial of transluminal EUS-guided biliary drainage via hepatogastrostomy vs. choledochoduodenostomy approaches", Endosc Int Open, 4, pp.E175~E181 (2016)
- Ochiai K, "Risk factors for stent migration into the abdominal cavity after endoscopic ultrasound-guided hepaticogastrostomy", J Clin Med, 10, pp.3111~ (2021)
- Martins FP, "Migration of a covered metallic stent following endoscopic ultrasound-guided hepaticogastrostomy : fatal complication", Endoscopy, 42(Suppl 2), pp.E126~E127 (2010)
- Okuno N, "Stent migration into the peritoneal cavity following endoscopic ultrasound-guided hepaticogastrostomy", Endoscopy, 47(Suppl 1 UCTN), pp.E311~ (2015)
- Nakai Y, "Safety and effectiveness of a long, partially covered metal stent for endoscopic ultrasound-guided hepaticogastrostomy in patients with malignant biliary obstruction", Endoscopy, 48, pp.1125~1128 (2016)
- Nakai Y, "Long-term outcomes of a long, partially covered metal stent for EUS-guided hepaticogastrostomy in patients with malignant biliary obstruction(with video)", Gastrointest Endosc, 92, pp.623~631 (2020)
- Cotton PB, "A lexicon for endoscopic adverse events : report of an ASGE workshop", Gastrointest Endosc, 71, pp.446~454 (2010)
- Isayama H, "TOKYO criteria 2014 for transpapillary biliary stenting", Dig Endosc, 27, pp.259~264 (2015)
- Asai S, "A novel partially covered metallic stent with a 20-mm long distal bare portion for EUS-guided hepaticogastrostomy", VideoGIE, 6, pp.322~324 (2021)
- Ishii S, "A pilot study of Spring Stopper Stents : novel partially covered self-expandable metallic stents with anti-migration properties for EUS-guided hepaticogastrostomy", Endosc Ultrasound, 12, pp.266~272 (2023)
- Eisenhauer EA, "New response evaluation criteria in solid tumours : revised RECIST guideline(version 1. 1)", Eur J Cancer, 45, pp.228~247 (2009)
- Artifon EL, "Hepaticogastrostomy or choledochoduodenostomy for distal malignant biliary obstruction after failed ERCP : is there any difference?", Gastrointest Endosc, 81, pp.950~959 (2015)
- Cho DH, "Long-term outcomes of a newly developed hybrid metal stent for EUS-guided biliary drainage(with videos)", Gastrointest Endosc, 85, pp.1067~1075 (2017)
- De Cassan C, "Use of partially covered and uncovered metallic prosthesis for endoscopic ultrasound-guided hepaticogastrostomy : results of a retrospective monocentric study", Endosc Ultrasound, 6, pp.329~335 (2017)
- Miyano A, "Clinical impact of the intra-scope channel stent release technique in preventing stent migration during EUS-guided hepaticogastrostomy", J Gastrointest Surg, 22, pp.1312~1318 (2018)
- Emmanuel J, "Endoscopic ultrasound-guided hepaticogastrostomy using a partially covered metal stent in patients with malignant biliary obstruction after failed endoscopic retrograde cholangiopancreatography", JGH Open, 4, pp.1059~1064 (2020)
- Yamamura M, "Partially covered self-expandable metal stent with antimigratory single flange plays important role during EUS-guided hepaticogastrostomy", Endosc Int Open, 10, pp.E209~E214 (2022)
- Paik WH, "Outcomes and limitations : EUS-guided hepaticogastrostomy", Endosc Ultrasound, 8(Suppl 1), pp.S44~S49 (2019)
- Ogura T, "Stent length is impact factor associated with stent patency in endoscopic ultrasound-guided hepaticogastrostomy", J Gastroenterol Hepatol, 30, pp.1748~1752 (2015)
- Wang K, "Assessment of efficacy and safety of EUS-guided biliary drainage : a systematic review", Gastrointest Endosc, 83, pp.1218~1227 (2016)
- Bories E, "Transgastric endoscopic ultrasonography-guided biliary drainage : results of a pilot study", Endoscopy, 39, pp.287~291 (2007)
- Paik WH, "Simplified fistula dilation technique and modified stent deployment maneuver for EUS-guided hepaticogastrostomy", World J Gastroenterol, 20, pp.5051~5059 (2014)
- Ogura T, "Novel method of endoscopic ultrasound-guided hepaticogastrostomy to prevent stent dysfunction", J Gastroenterol Hepatol, 29, pp.1815~1821 (2014)
- Panpimanmas S, "Endoscopic ultrasound-guided hepaticogastrostomy for advanced cholangiocarcinoma after failed stenting by endoscopic retrograde cholangiopancreatography", Asian J Surg, 36, pp.154~158 (2013)
- Attasaranya S, "The spectrum of endoscopic ultrasound intervention in biliary diseases : a single center’s experience in 31 cases", Gastroenterol Res Pract, 2012, pp.680753~ (2012)
- Kim TH, "Endoscopic ultrasound-guided biliary drainage with placement of a fully covered metal stent for malignant biliary obstruction", World J Gastroenterol, 18, pp.2526~2532 (2012)
- Ramírez-Luna MA, "Endoscopic ultrasound-guided biliodigestive drainage is a good alternative in patients with unresectable cancer", Endoscopy, 43, pp.826~830 (2011)
